HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luiz Augusto Casulari Selected Research

Cabergoline

6/2019Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
3/2018Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
1/2018Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up.
1/2018Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases.
6/2011Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR.
9/2010Management of prolactinomas in Brazil: an electronic survey.
7/2007Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
5/2007Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
1/2004Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luiz Augusto Casulari Research Topics

Disease

8Neoplasms (Cancer)
06/2019 - 01/2004
8Prolactinoma (Prolactinomas)
06/2019 - 03/2006
6Hyperprolactinemia
03/2018 - 06/2005
5Acromegaly
01/2020 - 02/2007
4Pituitary Neoplasms (Pituitary Adenoma)
06/2019 - 03/2006
4Insulin Resistance
01/2015 - 05/2007
2Obesity
10/2020 - 01/2007
2Ischemic Stroke
06/2019 - 07/2015
2Weight Loss (Weight Reduction)
03/2019 - 01/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 11/2009
2Hypogonadism (Hypergonadotropic Hypogonadism)
11/2009 - 08/2007
2Adenoma (Adenomas)
04/2008 - 07/2007
2Cushing Syndrome
11/2007 - 06/2007
2Pituitary ACTH Hypersecretion
06/2007 - 01/2004
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
05/2007 - 02/2007
2Hypothyroidism
02/2007 - 06/2005
1Metabolic Bone Diseases (Osteopenia)
01/2022
1Ascites
01/2022
1Osteoporosis
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Joint Diseases (Joint Disease)
01/2019
1Hypertension (High Blood Pressure)
01/2019
1Diabetes Mellitus
01/2019
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2016
1Candidemia
01/2016
1Postpartum Depression (Post-Natal Depression)
04/2015
1Glucose Intolerance
01/2015
1Type 2 Diabetes Mellitus (MODY)
01/2015
1Overweight
01/2015
1Nasal Obstruction
05/2013
1Fistula
05/2013
1Diabetes Insipidus
05/2013
1Kidney Diseases (Kidney Disease)
12/2010
1Chronic Kidney Failure (Chronic Renal Failure)
12/2010
1Papillary Carcinoma
02/2010
1Brain Injuries (Brain Injury)
12/2009
1Hyponatremia
12/2009
1Wasting Syndrome (Wasting Disease)
12/2009
1Inappropriate ADH Syndrome (SIADH)
12/2009
1Deafness (Deaf Mutism)
11/2008
1Pendred syndrome
11/2008
1Goiter
11/2008
1Pheochromocytoma
04/2008
1Tuberculosis (Tuberculoses)
04/2008
1Carcinoma (Carcinomatosis)
04/2008
1Myelolipoma
04/2008
1Lymphoma (Lymphomas)
04/2008
1Cysts
04/2008
1Anorexia Nervosa
11/2007
1Alcoholism (Alcohol Abuse)
11/2007

Drug/Important Bio-Agent (IBA)

9CabergolineFDA LinkGeneric
06/2019 - 01/2004
9ProlactinIBA
06/2019 - 06/2005
4Pharmaceutical PreparationsIBA
01/2020 - 02/2007
4Bromocriptine (Parlodel)FDA LinkGeneric
03/2018 - 01/2004
4Dopamine Agonists (Dopamine Agonist)IBA
03/2018 - 09/2010
4Hydrocortisone (Cortisol)FDA LinkGeneric
01/2015 - 06/2007
4Insulin (Novolin)FDA Link
01/2015 - 01/2007
3Growth Hormone (Somatotropin)IBA
09/2015 - 03/2006
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2019 - 03/2006
2polymeric prolactin (BPRL)IBA
03/2018 - 02/2007
2Insulin-Like Growth Factor I (IGF-1)IBA
09/2015 - 01/2007
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 07/2007
2Triglycerides (Triacylglycerol)IBA
11/2009 - 07/2007
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2007 - 06/2007
2Adrenocorticotropic Hormone (ACTH)FDA Link
06/2007 - 01/2004
2Contraceptive Agents (Contraceptives)IBA
05/2007 - 06/2005
1Vitamin DFDA LinkGeneric
01/2022
1CalciumIBA
01/2022
1Phosphorus (Red Phosphorus)IBA
01/2022
1Quetiapine Fumarate (Seroquel)FDA Link
06/2019
1Mirtazapine (Rexer)FDA LinkGeneric
06/2019
1Antipsychotic Agents (Antipsychotics)IBA
06/2019
1PlasticsIBA
01/2019
1amsonic acid (DAS)IBA
03/2018
1Biological ProductsIBA
01/2016
1Fluconazole (Zonal)FDA LinkGeneric
01/2016
1Corticotropin-Releasing HormoneIBA
04/2015
1Metformin (Glucophage)FDA LinkGeneric
01/2015
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2015
1ElectrolytesIBA
05/2013
1AcidsIBA
05/2013
1aryl hydrocarbon receptor-interacting proteinIBA
11/2010
1SodiumIBA
12/2009
1AldosteroneIBA
12/2009
1Vasopressins (Vasopressin)IBA
12/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2009
1PotassiumIBA
12/2009
1SaltsIBA
12/2009
1Testosterone (Sustanon)FDA Link
11/2009
1IodidesIBA
11/2008
1GlucocorticoidsIBA
11/2007

Therapy/Procedure

4Therapeutics
01/2020 - 01/2004
3Aftercare (After-Treatment)
01/2015 - 06/2005
2Body Contouring
10/2020 - 01/2019
1Plastic Surgery Procedures
10/2020
1Abdominoplasty
03/2019
1Length of Stay
07/2015
1Caloric Restriction
01/2015
1Renal Dialysis (Hemodialysis)
12/2010
1Thyroidectomy
02/2010